Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today. Revenues declined 41% year-over-year to $14.2 billion, missing estimates. The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat […]
“Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today. Revenues declined 41% year-over-year to $14.2 billion, missing estimates. The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat […]
· January 30, 2024
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today.
Revenues declined 41% year-over-year to $14.2 billion, missing estimates.
The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat expectations.
Pfizer expects revenues of $58.5-61.5 billion for the full year of 2024. Adjusted EPS is expected to be $2.05-2.25.
The stock stayed in green during premarket hours on Tuesday.
